Cervical Cancer Screening and Sexually Transmitted Infection Case Study PCP version 060614.

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

CASE Mrs Ford is a 29 years old lady who has been complaining of vaginal discharge for the past 3 days. Otherwise she is asymptomatic. Her PMH includes.
Cervical Cancer and Vaccines
Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
HIV/AIDS & STI Policy Guideline Clinical Management of Sexually Transmissible Infections DRAFT - 20 April 2001 FLOWCHARTS DEPARTMENT OF HEALTH Republic.
Adverse Events for VOICE Additional Examples. Is it an Adverse Event? Suppose a participant is found to have a grade 3 ALT after her Month 1 visit. Is.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
Sexually Transmitted Infections STI’s Overview: Types Incidence Transmission Symptoms Treatment Prevention.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Cervical Cancer Screening Cristin Colford, MD April 27,2010.
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Spotlight on Cervical Cancer Screening
Cervical Cancer: Prevention and Treatment
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
Women's Health ISU Student Health Promotions
Cervical Cancer Screening October What do you know about cervical cancer screening?
Cervical Cancer Screening
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Health Screening. Should you go for health screening? Health screening helps to discover if a person is suffering from a particular disease or condition,
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
MHD II Laboratory Session Cytology APRIL 24, 2014.
What Is HPV? Human Papillomaviruses have an icosahedral shape, contain DNA, and are non-enveloped There are at least 100 different types of HPV Over 30.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
+ STI’s Child Development. + Genital Herpes Symptoms: Some girls will notice itching and a breakout of small, red blisters and open sores—they're usually.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Product Use Management MTN 020 Training. Objectives- study product tab  Identify the conditions that would require a product hold or discontinuation.
Current guidelines for Cervical Cancer Screening
Hot Topics Clinical Medicine ACHA Annual Meeting Boston, MA May 31, 2013.
HPI A 23 year-old female comes to your office complaining of vaginal discharge, itching, and burning with urination for several days. The symptoms had.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
International Scientific Congress for Students, Young Physicians and Pharmacists Marisiensis 2014.
NYU Medicine Grand Rounds Clinical Vignette Himali Weerahandi, PGY3 March 6, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
Adult Medical-Surgical Nursing
Chronic Pelvic Pain Case Study PCP version
Cervical Cancer Screening Guidelines Update
Cervical Cancer Screening and Sexually Transmitted Infections Case Studies.
Sexually Transmitted Diseases Caused by. Trichomonas.
Copyright ©2012 Delmar, Cengage Learning. All rights reserved. Chapter 41 OB/GYN Examinations.
Premalignant lesions of the cervix. Applied anatomy.
Chronic Pelvic Pain Case Study Interprofessional version
To pap or not to pap: and what to do when you do Kimberly Swan MD Minimally Invasive Gynecologic Surgery Assistant Professor Ob/Gyn University of Kansas.
HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Slideset on: Duerr A, Paramsothy P, Jamieson DJ, et al. Effect of HIV infection.
New standard in Vaginitis treatment
Cervical Screening: Do I Really Need a Pap Test April 2010.
1 Cervical Cancer Screening Updates Dr. GORDON JOHNSON.
Vaginal Infections NURS 541: Women’s Healthcare – Diagnosis and Management.
INTRODUCTION: CERVICAL CANCER SCREENING
Cervical Cancer in California
Dr.Jyothi Ranganathan Head lab operations SRL Ltd Bangalore
Updates on Pap Smear Guidelines 2014
Overview.
Ch. 18 Male/Female Reproduction
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
SH-sheikhhasani Gyn-oncologist
Medical-Surgical Nursing: Concepts & Practice
Presentation transcript:

Cervical Cancer Screening and Sexually Transmitted Infection Case Study PCP version

VETERANS HEALTH ADMINISTRATION Joyce, a 32-year-old returning Veteran, comes in for a well-woman visit. She is due for cervical cancer screening. Vital signs: T 97.9 F, HR 75, BP 122/82, RR 17; 5’6”, 141 lbs., BMI 22.8, pain 0/10 2 Case Study

VETERANS HEALTH ADMINISTRATION Table Discussion What are the Women’s Health PACT members’ roles in facilitating cervical cancer screening, and tracking and communicating results? 3

VETERANS HEALTH ADMINISTRATION WH PACT and Cervical Cancer Screening Pap tracking: Team members can track when samples were sent, when they were resulted, and when/how the patient was notified of the results Abnormal Pap follow-up: Team members can track appropriate follow-up to ensure patients get the right care Identifying patients who are overdue for Paps: Team members can pull lists of patients who are overdue for cervical cancer screening and reach out to schedule them. Other ideas? 4

VETERANS HEALTH ADMINISTRATION Q1: Joyce’s Pap results come back as ASC-US (atypical squamous cells of undetermined significance). What would you do next? A.If liquid-based cytology was used, await reflex HPV testing results. If positive, refer to colposcopy. B.Refer immediately to colposcopy. C.Repeat Pap test in 6 months. D.Repeat Pap test in 12 months. 5

VETERANS HEALTH ADMINISTRATION A.If liquid based cytology was used, await reflex HPV testing results. If positive, refer to colposcopy. B.Refer immediately to colposcopy C.Repeat Pap test in 6 months D.Repeat Pap test in 12 months 6 Q1: Joyce’s Pap results come back as ASC-US (atypical squamous cells of undetermined significance). What would you do next?

VETERANS HEALTH ADMINISTRATION Discussion Points Option A: Reflex testing for HPV (if liquid cytology is used, or if a separate sample is collected at time of the Pap) is preferred for patient convenience and cost-effectiveness − Women who test HPV negative: risk of harboring CIN 2/3 is less than 2%; can perform co-testing in 3 years − Women who test HPV positive: refer for colposcopy due to 15-27% chance of CIN 2/3+ (unless under the age of 25 where repeat testing in 1 year is suggested) Option B: Immediate colposcopy is no longer recommended Option D: Repeat Pap in 12 months is acceptable 7

VETERANS HEALTH ADMINISTRATION Q2: What if Joyce’s Pap results come back as L-SIL (low-grade squamous intraepithelial lesion)? Co-testing wasn’t performed. What is your next step? 8 A.Repeat Pap smear immediately B.Repeat Pap smear in 6 months C.Refer for colposcopy

VETERANS HEALTH ADMINISTRATION 9 A.Repeat Pap smear immediately B.Repeat Pap smear in 6 months C.Refer for colposcopy Q2: What if Joyce’s Pap results come back as L-SIL (low-grade squamous intraepithelial lesion)? Co-testing wasn’t performed. What is your next step?

VETERANS HEALTH ADMINISTRATION Discussion Points Data shows the natural history of LSIL approximates that of HPV+ ASCUS LSIL without known HPV status is treated as if HPV+ and goes directly for colposcopy 10

VETERANS HEALTH ADMINISTRATION A.Repeat Pap smear immediately B.Repeat Pap smear in 6-12 months C.Refer to Gynecology for colposcopy and/or other procedures 11 Q3: What if Joyce’s Pap results come back as H-SIL (low-grade squamous intraepithelial lesion)? Co-testing wasn’t performed. What is your next step?

VETERANS HEALTH ADMINISTRATION A.Repeat Pap smear immediately B.Repeat Pap smear in 6-12 months C.Refer to Gynecology for colposcopy and/or other procedures 12 Q3: What if Joyce’s Pap results come back as H-SIL (low-grade squamous intraepithelial lesion)? Co-testing wasn’t performed. What is your next step?

VETERANS HEALTH ADMINISTRATION Among women with H-SIL cytology results, greater than 70% have been reported to have CIN2 or CIN3, and 1- 5% harbor invasive cancer. Therefore, a referral to a gynecologist for colposcopy is essential. Discussion Points 13

VETERANS HEALTH ADMINISTRATION 14 Q4. Six months later, Joyce presents with complaints of vaginal discharge, burning and itching. How would you like to see this issue triaged?

VETERANS HEALTH ADMINISTRATION LMP Change in color, volume, or odor of discharge Itching Burning Urinary frequency or urgency, or painful urination Intermenstrual or post-coital spotting Acute lower abdominal/pelvic pain or low back pain Pain during intercourse Fever, chills Nausea or vomiting 15 Q4. Six months later, Joyce presents with complaints of vaginal discharge, burning, and itching. How would you like to see this issue triaged?

VETERANS HEALTH ADMINISTRATION Case Study (continued) Joyce comes in for an appointment that afternoon. In response to sexual history queries, she reports a new sexual partner and inconsistent condom use. 16

VETERANS HEALTH ADMINISTRATION Q5. What are the next diagnostic steps? 17 A.Vaginal pH B.Amine (whiff test) C.Potassium hydroxide (KOH) microscopy D.Normal saline microscopy E.BD Affirm TM point-of-care testing F.All of the above

VETERANS HEALTH ADMINISTRATION A.Vaginal pH B.Amine (whiff test) C.Potassium hydroxide (KOH) microscopy D.Normal saline microscopy E.BD Affirm TM point-of-care testing F.All of the above (if available) 18 Q5. What are the next diagnostic steps?

VETERANS HEALTH ADMINISTRATION Obtain specimens from lateral vaginal wall for laboratory evaluation. Evaluations should include vaginal pH, amine (whiff) test, saline and 10% potassium hydroxide (KOH) microscopy. Normal pH ( 4.5 has a limited differential diagnosis. Perform whiff test for amines by placing a drop of 10% KOH on vaginal secretions and checking for a fishy odor. Saline microscopy can identify trichomonads and clue cells. KOH microscopy can identify pseudohyphae and yeast buds. BD Affirm TM can identify candida species, trichomonas vaginalis, and gardnerella vaginalis. Turnaround time may vary by facility. Discussion 19

VETERANS HEALTH ADMINISTRATION Table Discussion How does your team handle vaginal discharge specimens? Do you have access to pH paper in your clinic? Microscopy? Other rapid testing for vaginitis? How can each PACT member contribute to the management and facilitation of vaginitis presentations? 20

VETERANS HEALTH ADMINISTRATION Q6. Joyce’s exam reveals a frothy, yellow-green discharge with erythematous punctuate lesions on the cervix. A whiff test is negative and pH is normal. What is the most likely diagnosis? A.Bacterial vaginosis B.Candidiasis C.Trichomoniasis D.Physiologic discharge E.Atrophic vaginitis 21

VETERANS HEALTH ADMINISTRATION A.Bacterial vaginosis B.Candidiasis C.Trichomoniasis D.Physiologic discharge E.Atrophic vaginitis 22 Q6. Joyce’s exam reveals a frothy, yellow-green discharge with erythematous punctuate lesions on the cervix. A whiff test is negative and pH is normal. What is the most likely diagnosis?

VETERANS HEALTH ADMINISTRATION When and how do you counsel your patients on STI risk, screening, and treatment? Who do your patients ask about STI risk? What are some approaches your PACT can use to inform and encourage STI awareness and screening? 23 Table Discussion

VETERANS HEALTH ADMINISTRATION Q7. What would you do if Joyce’s symptoms don’t improve? 24

VETERANS HEALTH ADMINISTRATION Query about unprotected sex, other partners, and adherence to medication by Joyce and her partner Reassess for other causes of vaginitis after treatment (i.e., candida after exposure to an antibiotic) Joyce’s partner should seek treatment for trichomonas as it is a sexually transmitted infection Q7. What would you do if Joyce’s symptoms don’t improve? 25